Stay updated on Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial
Sign up to get notified when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.

Latest updates to the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedFooter now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedRevision metadata updated from v3.4.1 to v3.4.2. This is a minor metadata update and does not affect the study information.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page footer shows a revision update, with Revision: v3.4.1 added and Revision: v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded a glossary toggle; capitalization tweaks for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act data'; and updated the page revision to v3.4.0.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This appears to be an internal version change with no visible impact on study details.SummaryDifference0.1%

- Check81 days agoChange DetectedLocations section now lists study sites by state (Alabama, California, Massachusetts, North Carolina, Ohio, Texas, Washington). The page revision has been updated to v3.3.3 (replacing v3.3.2).SummaryDifference0.8%

Stay in the know with updates to Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.